Uwe Schirmer

发表

QSEA—modelling of genome-wide DNA methylation from sequencing enrichment experiments

H. Sültmann, R. Herwig, I. Fichtner, 2016, Nucleic acids research.

Process Development for Additive Manufacturing of Alumina Toughened Zirconia for 3D Structures by Means of Two-Photon Absorption Technique

Uwe Schirmer, R. Houbertz, G. Hildebrand, 2021, Ceramics.

Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens

P. Altevogt, H. Fiegl, E. Müller-Holzner, 2013, BMC Cancer.

L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.

P. Altevogt, I. Vergote, M. Netzer, 2013, Journal of the National Cancer Institute.

Development of a system of heparin multilayers on titanium surfaces for dual growth factor release.

H. Schliephake, C. Behrens, Uwe Schirmer, 2022, Journal of biomedical materials research. Part A.

L1CAM expression in endometrial carcinomas is regulated by usage of two different promoter regions

P. Altevogt, C. Geismann, S. Sebens, 2010, BMC Molecular Biology.

P. Altevogt, Uwe Schirmer, S. Bondong, 2012, Cell adhesion & migration.

Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance

H. Lehrach, M. Vingron, M. Odenthal, 2018, Genome Medicine.

Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients

E. Dahl, H. Sültmann, Michael Thomas, 2016, PloS one.

Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma

P. Altevogt, H. Sültmann, R. Zeillinger, 2014, Oncotarget.

miR-21-3p is a positive regulator of L1CAM in several human carcinomas.

P. Altevogt, R. Blaheta, H. Fiegl, 2014, Cancer letters.

Binding of the transcription factor Slug to the L1CAM promoter is essential for transforming growth factor-β1 (TGF-β)-induced L1CAM expression in human pancreatic ductal adenocarcinoma cells.

P. Altevogt, C. Geismann, A. Arlt, 2010, International journal of oncology.

L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer

G. Kristiansen, P. Altevogt, H. Moch, 2011, Molecular Cancer.

Up‐regulation of L1CAM is linked to loss of hormone receptors and E‐cadherin in aggressive subtypes of endometrial carcinomas

P. Altevogt, C. Marth, E. Müller-Holzner, 2010, The Journal of pathology.

Tailored Polyelectrolyte Multilayer Systems by Variation of Polyelectrolyte Composition and EDC/NHS Cross-Linking: Controlled Drug Release vs. Drug Reservoir Capabilities and Cellular Response for Improved Osseointegration

H. Schliephake, C. Behrens, Uwe Schirmer, 2022, Polymers.

L1CAM is expressed in triple-negative breast cancers and is inversely correlated with Androgen receptor

P. Altevogt, E. Müller-Holzner, A. Zeimet, 2014, BMC Cancer.

Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patients

H. Sültmann, Michael Thomas, T. Muley, 2016, Scientific Reports.

EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-κB activation.

P. Altevogt, S. Sebens, Uwe Schirmer, 2012, Carcinogenesis.

Collagen-Based Osteogenic Nanocoating of Microrough Titanium Surfaces

H. Schliephake, C. Behrens, Uwe Schirmer, 2022, International journal of molecular sciences.